Under a restructuring operation declared in late October by GlaxoSmithKline, largest pharmaceutical company of UK is going to lay off 900 employees at Research Triangle Park site in North Carolina as

The US Food and Drug Administration has approved a new drug from Amgen for treatment of B-cell acute lymphoblastic leukemia.

The Access to Medicines Index ranks the 20 topmost drug-makers on their efforts to improve access to medicines in developing nations.

Doctors in the Houston area are being paid by drug companies for their clinical research as well as activities like consulting and travel, a fresh analysis of data released by the Centers for Medicare & Medicaid Services showed.

According to the analysis, 16 of Houston area doctors received more than $10,000 in combined compensation last year. The data, which is a part of a federal transparency measure introduced in the 2010 Affordable Care Act, proved that there is a financial relationship between drug companies and doctors.

Allergan Inc has announced restructuring and the management plan to cut 13% of the workforce to improve efficiency. The move is intended to increase profits for the company over next six years. The company is also fighting a hostile bid from Valeant Pharmaceuticals International Inc.

The cost reductions have been claimed by the maker of anti-wrinkle drug Botox as a good way to spur annual earnings by more than 20% per year between 2014 and 2019.

AbbVie bio-pharmaceutical company had signed a deal of $55 billion with Shire PLC on Friday. The deal between two reputed companies is considered as largest deal for the year.

To cut down the tax bill, the North Chicago-based AbbVie company decided to join hands with Shire. The tax rate of the company will be reduced to 13 % from 22 % in 2016.

In a Friday morning conference call with analysts, AbbVie Chief Executive Officer Richard Gonzalez said, "AbbVie's rationale for the deal goes well beyond the tax impact. He added that Shire's portfolio of drugs is an "excellent strategic fit".